Inconsistences in Prescribing Epinephrine Autoinjectors

Area of Science:

• Allergy and Immunology
• Clinical Medicine

Background:

• Self-administered epinephrine (self-epi) is a cornerstone in managing anaphylaxis risk.
• Discrepancies exist in prescribing thresholds for self-epi between food allergies and venom allergies.

Purpose of the Study:

• To examine the rationale and implications of self-epi prescription in anaphylaxis management.
• To compare the indications for self-epi in food versus venom allergies.

Main Methods:

• Comparative analysis of current clinical practices and evidence regarding self-epi prescription.
• Review of studies on the efficacy and impact of self-epi on patient quality of life.

Main Results:

• Self-epi is often recommended for food allergies with <5% anaphylaxis risk, while similar risk in venom allergy may not warrant it.
• Evidence does not consistently show self-epi reduces hospitalization or fatal anaphylaxis rates.
• Studies indicate self-epi may negatively impact quality of life, potentially increasing perceived risk.

Conclusions:

• The rationale for self-epi should prioritize patient empowerment and quality of life over solely risk reduction.
• Prescribing self-epi, especially for low-risk anaphylaxis, requires careful consideration of both benefits and potential harms.